Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine: A prospective observational study

Acta Cardiologica

Volumn 63, Issue 5, 2008, Pages 571-577

  Luermans, Justin G L M ^a   Post, Martijn C ^a   Temmerman, Frederik ^b   Thijs, Vincent ^b   Schonewille, Wouter J ^a   Plokker, H W Thijs ^a   Suttorp, Maarten J ^a   Budts, Werner I H L ^b  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Migraine; Patent foramen ovale; Transcatheter closure

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPYRIDAMOLE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; NETHERLANDS; OBSERVATIONAL STUDY; PATENT FORAMEN OVALE; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; PREVALENCE; QUESTIONNAIRE; STROKE;

ADOLESCENT; ADULT; FEMALE; FORAMEN OVALE, PATENT; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NETHERLANDS; PREVALENCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; YOUNG ADULT;

EID: 56049094117     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.63.5.2033223     Document Type: Article

References (30)

1. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984; 59: 17-20.
2. Anzola GP, Magoni M, Guindani M, Rozzini L, Dalla VG. Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology 1999; 52: 1622-5.
3. Dalla VG, Guindani M, Zavarise P, Griffini S, Pezzini A, Padovani A. Prevalence of patent foramen ovale in a large series of patients with migraine with aura, migraine without aura and cluster headache, and relationship with clinical phenotype. J Headache Pain 2005; 6: 328-30.
4. Wilmshurst P, Nightingale S. Relationship between migraine and cardiac and pulmonary right-to-left shunts. Clin Sci (Lond) 2001; 100: 215-20.
5. Henry P, Michel P, Brochet B, Dartigues JF, Tison S, Salamon R. A nationwide survey of migraine in France: prevalence and clinical features in adults. GRIM Cephalalgia 1992; 12: 229-37.
6. Lusic I. Population variation in migraine prevalence - the unsolved problem. Coll Antropol 2001; 25: 695-701.
7. Stewart WF, Shechter A, Rasmussen BK. Migraine prevalence. A review of population-based studies. Neurology 1994; 44 (6 Suppl 4): S17-S23.
8. Post MC, Thijs V, Herroelen L, Budts WI. Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology 2004; 62: 1439-40.
9. Azarbal B, Tobis J, Suh W, Chan V, Dao C, Gaster R. Association of interatrial shunts and migraine headaches: impact of transcatheter closure. J Am Coll Cardiol 2005; 45: 489-92.
10. Morandi E, Anzola UP, Angeli S, Melzi G, Onorato E. Transcatheter closure of patent foramen ovale: a new migraine treatment? J Interv Cardiol 2003; 16: 39-42.
11. Reisman M, Christofferson RD, Jesurum J, Olsen JV, Spencer MP, Krabill KA, Diehl L, Aurora S, Gray WA. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol 2005; 45: 493-5.
12. Schwerzmann M, Wiher S, Nedeltchev K, Mattle HP, Wahl A, Seiler C, Meier B, Windecker S. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 2004; 62: 1399-401.
13. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000; 356: 1648-51.
14. Anzola UP, Frisoni GB, Morandi E, Casilli F, Onorato E. Shunt-associated migraine responds favorably to atrial septal repair: a case-control study. Stroke 2006; 37: 430-4.
15. Post MC, Van Deyk K, Budts W. Percutaneous closure of a patent foramen ovale: single-centre experience using different types of devices and mid-term outcome. Acta Cardiol 2005; 60: 515-9.
16. Mortelmans K, Post M, Thijs V, Herroelen L, Budts W. The influence of percutaneous atrial septal defect closure on the occurrence of migraine. Eur Heart J 2005; 26: 1533-7.
17. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004; 24 Suppl 1: 9-160.
18. Wilmshurst PT, Pearson MJ, Nightingale S, Walsh KP, Morrison WL. Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura. Heart 2004; 90: 1315-20.
19. Etminan M, Takkouche B, Isorna FC, Samii A. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 2005; 330: 63.
20. Zeller JA, Frahm K, Baron R, Stingele R, Deuschl G. Platelet-leukocyte interaction and platelet activation in migraine: a link to ischemic stroke? J Neurol Neurosurg Psychiatry 2004; 75: 984-7.
21. Lechat P, Mas JL, Lascault G, Loron P, Theard M, Klimczac M, Drobinski G, Thomas D, Grosgogeat Y. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med; 318: 1148-52.
22. Venketasubramanian N, Sacco RL, Di TM, Sherman D, Homma S, Mohr JP Vascular distribution of paradoxical emboli by transcranial Doppler. Neurology 1993; 43: 1533-5.
23. Kruit MC, van Buchem MA, Hofman PA, Bakkers JT, Terwindt GM, Ferrari MD, Launer LJ. Migraine as a risk factor for subclinical brain lesions. JAMA 2004; 291: 427-34.
24. Lipton RB, Goldstein J, Baggish JS, Yataco AR, Sorrentino JV, Quiring JN. Aspirin is efficacious for the treatment of acute migraine. Headache 2005; 45: 283-92.
25. Fragoso YD. Reduction of migraine attacks during the use of warfarin. Headache 1997; 37: 667-8.
26. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. Heart 2005; 91: 1173-5.
27. Diener HC, Hartung E, Chrubasik J, Evers S, Schoenen J, Eikermann A, Latta U, Hauke W. A comparative study of oral acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomized, controlled, doubleblind, parallel group phase III study. Cephalalgia 2001; 21: 120-8.
28. Dowson A, Mullen MJ, Peatfield R, Muir K, Khan AA, Wells C, Lipscombe SL, Rees T, De Giovanni JV, Morrison WL, Hildick-Smith D, Elrington G, Hillis WS, Malik IS, Rickards A. Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008; 117: 1397-404.
29. Lapergue B, Rosso C, Hadrane L, Labreuche J, Abboud H, Brochet E, Juliard JM, Amarenco P. Frequency of migraine attacks following stroke starts to decrease before PFO closure. Neurology 2006; 67: 1099-100.
30. Van der Kuy PH, Lohman JJ. A quantification of the placebo response in migraine prophylaxis. Cephalalgia 2002; 22: 265-70.